NOTICE: Labnodes will be unavailable on Sunday March 4th for scheduled maintenance from 6-11AM central time.
Aaron Bowman
Associate Professor, Pediatrics, Neurology and Biochemistry
Last active: 4/26/2017

  1. Relationships Between Essential Manganese Biology and Manganese Toxicity in Neurological Disease. Pfalzer AC, Bowman AB (2017) Curr Environ Health Rep
    › Primary publication · 28417441 (PubMed)
  2. Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington's disease mouse model. Bichell TJ, Wegrzynowicz M, Grace Tipps K, Bradley EM, Uhouse MA, Bryan M, Horning K, Fisher N, Dudek K, Halbesma T, Umashanker P, Stubbs AD, Holt HK, Kwakye GF, Tidball AM, Colbran RJ, Aschner M, Diana Neely M, Di Pardo A, Maglione V, Osmand A, Bowman AB (2017) Biochim Biophys Acta
    › Primary publication · 28213125 (PubMed)
  3. BXD recombinant inbred strains participate in social preference, anxiety and depression behaviors along sex-differences in cytokines and tactile allodynia. López-Granero C, Antunes Dos Santos A, Ferrer B, Culbreth M, Chakraborty S, Barrasa A, Gulinello M, Bowman AB, Aschner M (2017) Psychoneuroendocrinology : 92-98
    › Primary publication · 28324704 (PubMed)
  4. Accelerated differentiation of human induced pluripotent stem cells to blood-brain barrier endothelial cells. Hollmann EK, Bailey AK, Potharazu AV, Neely MD, Bowman AB, Lippmann ES (2017) Fluids Barriers CNS 14(1): 9
    › Primary publication · 28407791 (PubMed) · PMC5390351 (PubMed Central)
  5. Sex- and structure-specific differences in antioxidant responses to methylmercury during early development. Ruszkiewicz JA, Bowman AB, Farina M, Rocha JB, Aschner M (2016) Neurotoxicology : 118-126
    › Primary publication · 27456245 (PubMed)
  6. Metabolic consequences of inflammatory disruption of the blood-brain barrier in an organ-on-chip model of the human neurovascular unit. Brown JA, Codreanu SG, Shi M, Sherrod SD, Markov DA, Neely MD, Britt CM, Hoilett OS, Reiserer RS, Samson PC, McCawley LJ, Webb DJ, Bowman AB, McLean JA, Wikswo JP (2016) J Neuroinflammation 13(1): 306
    › Primary publication · 27955696 (PubMed) · PMC5153753 (PubMed Central)
  7. "Manganese-induced neurotoxicity: a review of its behavioral consequences and neuroprotective strategies". Peres TV, Schettinger MR, Chen P, Carvalho F, Avila DS, Bowman AB, Aschner M (2016) BMC Pharmacol Toxicol 17(1): 57
    › Primary publication · 27814772 (PubMed) · PMC5097420 (PubMed Central)
  8. Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson's Disease. Claassen DO, Dobolyi DG, Isaacs DA, Roman OC, Herb J, Wylie SA, Neimat JS, Donahue MJ, Hedera P, Zald DH, Landman BA, Bowman AB, Dawant BM, Rane S (2016) Aging Dis 7(3): 220-9
    › Primary publication · 27330836 (PubMed) · PMC4898918 (PubMed Central)
  9. Genomic Instability Associated with p53 Knockdown in the Generation of Huntington's Disease Human Induced Pluripotent Stem Cells. Tidball AM, Neely MD, Chamberlin R, Aboud AA, Kumar KK, Han B, Bryan MR, Aschner M, Ess KC, Bowman AB (2016) PLoS One 11(3): e0150372
    › Primary publication · 26982737 (PubMed) · PMC4794230 (PubMed Central)
  10. Embryonic Mutant Huntingtin Aggregate Formation in Mouse Models of Huntington's Disease. Osmand AP, Bichell TJ, Bowman AB, Bates GP (2016) J Huntingtons Dis 5(4): 343-346
    › Primary publication · 27886014 (PubMed) · PMC5181660 (PubMed Central)